[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 54, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Mr. Andrew  Knowles M.Sc.", "title": "VP of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Caitlin  Webster CIPD, M.Sc.", "title": "Director of Talent Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.41, "open": 3.41, "dayLow": 3.33, "dayHigh": 3.55, "regularMarketPreviousClose": 3.41, "regularMarketOpen": 3.41, "regularMarketDayLow": 3.33, "regularMarketDayHigh": 3.55, "payoutRatio": 0.0, "beta": 0.702, "forwardPE": -5.3181815, "volume": 3483400, "regularMarketVolume": 3483400, "averageVolume": 5053461, "averageVolume10days": 5437810, "averageDailyVolume10Day": 5437810, "bid": 2.51, "ask": 4.28, "bidSize": 2, "askSize": 2, "marketCap": 1050665984, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 6.515, "allTimeHigh": 71.91, "allTimeLow": 1.891, "priceToSalesTrailing12Months": 29.742844, "fiftyDayAverage": 5.0054, "twoHundredDayAverage": 3.623375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 697212032, "profitMargins": 0.0, "floatShares": 203251491, "sharesOutstanding": 299335048, "sharesShort": 55161166, "sharesShortPriorMonth": 46141939, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.18450001, "heldPercentInsiders": 0.22903, "heldPercentInstitutions": 0.37625998, "shortRatio": 9.69, "shortPercentOfFloat": 0.2394, "impliedSharesOutstanding": 299335048, "bookValue": 3.26, "priceToBook": 1.0766871, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -171676992, "trailingEps": -0.59, "forwardEps": -0.66, "enterpriseToRevenue": 19.737, "enterpriseToEbitda": -2.997, "52WeekChange": 0.15593219, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 3.51, "targetHighPrice": 17.0, "targetLowPrice": 7.0, "targetMeanPrice": 10.0, "targetMedianPrice": 9.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 495672000, "totalCashPerShare": 1.656, "ebitda": -232664000, "totalDebt": 142218000, "quickRatio": 8.485, "currentRatio": 10.103, "totalRevenue": 35325000, "debtToEquity": 14.752, "revenuePerShare": 0.119, "returnOnAssets": -0.10426, "returnOnEquity": -0.16814, "grossProfits": -147487008, "freeCashflow": -241470496, "operatingCashflow": -104552000, "revenueGrowth": 0.376, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -8.51792, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "corporateActions": [], "postMarketTime": 1763771955, "regularMarketTime": 1763758801, "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.93255, "regularMarketPrice": 3.51, "marketState": "CLOSED", "earningsCallTimestampStart": 1762466400, "earningsCallTimestampEnd": 1762466400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.59, "epsForward": -0.66, "epsCurrentYear": -0.64333, "priceEpsCurrentYear": -5.455987, "fiftyDayAverageChange": -1.4954002, "fiftyDayAverageChangePercent": -0.29875737, "twoHundredDayAverageChange": -0.11337495, "twoHundredDayAverageChangePercent": -0.031289876, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": 0.23361625, "postMarketPrice": 3.5182, "postMarketChange": 0.00819993, "regularMarketChange": 0.0999999, "regularMarketDayRange": "3.33 - 3.55", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 5053461, "fiftyTwoWeekLowChange": 1.619, "fiftyTwoWeekLowChangePercent": 0.8561607, "fiftyTwoWeekRange": "1.891 - 6.515", "fiftyTwoWeekHighChange": -3.0049999, "fiftyTwoWeekHighChangePercent": -0.46124327, "fiftyTwoWeekChangePercent": 15.593219, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]